510(k) K033915

MODIFICATION TO SERAQUEST EB VCA IGG by Quest Intl., Inc. — Product Code LSE

K033915 is an FDA 510(k) premarket notification submitted by Quest Intl., Inc. for the device "MODIFICATION TO SERAQUEST EB VCA IGG". The FDA issued a decision of Substantially Equivalent on January 16, 2004. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Quest Intl., Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 16, 2004
Date Received
December 18, 2003
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type